NL-OMON48493已完成不适用
PREcision Event Monitoring of PatienTs with Heart Failure - PREEMPT-HF
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Subject is age 18 or above, or of legal age to give informed consent specific
- •country and national laws
- •Subject has a documented diagnosis of heart failure
- •Subject has a Boston Scientific CRT-D or ICD device implant that has
- •HeartLogic,
- •with Heart Failure Sensors turned ON, Respiratory Sensor turned ON, and Sleep
- •Incline Sensor turned ON
- •Subject has an active bipolar RV lead implant.
- •Subject is enrolled in LATITUDE (NXT 5.0 or future version), and is willing
- •remotely monitored from the baseline visit for approximately 12 months with
- •HeartLogic disabled
排除标准
- •Subject has received or is scheduled to receive a heart transplant or
- •ventricular assist device (VAD).
- •Subject is enrolled in any concurrent clinical study without prior
- •Boston Scientific written approval (excluding registries).
- •Subject has a life expectancy of less than 12 months.
- •Subject has a history of non-compliance to medical care or known
- •inability to comply with requirements of the clinical study protocol.
研究者
相似试验
招募中
Unknown
Hativ electrocardiogram monitoring on Patients with ChemotherapyKCT0009198Chonnam National University Hospital Hwasun Hospital300
招募中
Unknown
Study on the effectiveness of portable electrocardiogram devices in patients with arrhythmia symptomsKCT0009176Yonsei University, Wonju Severance Christian Hospital588
尚未招募
Unknown
Hativ® ELectrocardiogram monitoring on Patients with Sinus rhythm(HELP-S trial)Diseases of the circulatory systemKCT0009304Hallym University Medical Center-Dongtan600
已完成
不适用
Remote Monitoring of Heart Failure Patients with a Cardiovascular Implantable Electronic Device: The Patient Perspective (REMOTE-CIED study)10019280heart failureNL-OMON44924niversitair Medisch Centrum Utrecht347
进行中（未招募）
不适用
ASSESSMENT OF FUNCTION OF HEART DURING TREATMENT FOR ESOPHAGEAL CANCERCTRI/2015/02/005502PGIMER